Literature DB >> 9445328

Stroke risk management: changes in mainstream practice.

L Kalra1, I Perez, A Melbourn.   

Abstract

BACKGROUND: Research shows that identification and control of risk factors reduces ischemic stroke. The impact of this evidence and health initiatives on mainstream practice remains unknown.
METHODS: The purpose of this observational study was to investigate prior management of risk factors (hypertension, atrial fibrillation, previous stroke/transient ischemic attacks) in patients with acute cerebral infarction. Data were collected on the frequency of known risk factors before the incident stroke and their management compared with predefined criteria for appropriateness. The proportion of patients receiving treatment for risk factors before the acute episode was studied over 3 years.
RESULTS: One thousand seventy-four patients (median age, 76 years; 60% women) were included in the study over 3 years. The proportion of patients with known hypertension (41% to 46%), diabetes (12% to 13%), previous stroke or transient ischemic attack (TIA) (21% to 31%), and atrial fibrillation (16% to 21%) remained stable. Overall, approximately 45% patients with atrial fibrillation, 60% patients with hypertension, and 70% with cerebrovascular disease were being actively managed. Time trends analysis showed a significant increase in the proportion of patients being treated for risk due to known cerebrovascular disease (59% to 85%), atrial fibrillation (18% to 59%), ischemic heart disease (35% to 72%), and carotid disease (13% to 85%) between the first and third year. The proportion of patients receiving treatment for hypertension remained unchanged. Patients with preexisting symptomatic vascular disease were more likely to receive appropriate risk management compared with asymptomatic patients (72% versus 46%, P<.001).
CONCLUSIONS: Although a significant number of ischemic events remain potentially preventable, there appears to be a positive trend in improved control of stroke risk.

Entities:  

Mesh:

Year:  1998        PMID: 9445328     DOI: 10.1161/01.str.29.1.53

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  5 in total

1.  Use of antithrombotic measures for stroke prevention in atrial fibrillation.

Authors:  I Perez; A Melbourn; L Kalra
Journal:  Heart       Date:  1999-11       Impact factor: 5.994

2.  Stroke and atrial fibrillation: is stroke prevention treatment appropriate beforehand? SAFE I Study Investigators.

Authors:  D Deplanque; F Corea; C Arquizan; L Parnetti; J L Mas; V Gallai; D Leys
Journal:  Heart       Date:  1999-11       Impact factor: 5.994

3.  Prevalence of risk factors for ischaemic stroke and their treatment among a cohort of stroke patients in Dublin.

Authors:  R McDonnell; C W Fan; Z Johnson; M Crowe
Journal:  Ir J Med Sci       Date:  2000 Oct-Dec       Impact factor: 1.568

4.  Cardiovascular risk in survivors of stroke.

Authors:  Susan P Kopunek; Kathleen M Michael; Marianne Shaughnessy; Barbara Resnick; Eun-Shim Nahm; Jill Whitall; Andrew Goldberg; Richard F Macko
Journal:  Am J Prev Med       Date:  2007-05       Impact factor: 5.043

5.  Stroke prevention and atrial fibrillation: reasons leading to an inappropriate management. Main results of the SAFE II study.

Authors:  Dominique Deplanque; Didier Leys; Lucilla Parnetti; Reinhold Schmidt; Jose Ferro; Jacques De Reuck; Jean-Louis Mas; Virgilio Gallai
Journal:  Br J Clin Pharmacol       Date:  2004-06       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.